MLND Millendo Therapeutics 8-K2021Millendo Therapeutics Provides Pipeline and Business Update
5 Jan 21
Content Analysis
?
| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
|
|
MLND 8-K Filings
- 5 Jan 21 Millendo Therapeutics Provides Pipeline and Business Update
- 24 Sep 20 Millendo Therapeutics Announces Initiation of First-in-Human Clinical Trial of MLE-301, a Selective NK3R Antagonist
- 23 Jun 20 Millendo Therapeutics Provides Corporate and Pipeline Update
- 6 Apr 20 Cost Associated with Exit or Disposal Activities
Filing View
Search this filing
Table of Contents
Get all this for free
- Email alerts for new filings that match keywords or companies
- Plot, compare & download financial data
- 10-K & 10-Q redlined comparisons
- Advanced filing search & analysis
- Sentiment analysis for financial filings
- Favorites, search history, and more…